Boston Scientific Corporation (BSX)
-NYSE 9.40 
0.14(1.47%) 04:00 SGT|After Hours
:
9.40 0.00 (0.00%) 04:32 SGT
| Prev Close: | 9.54 |
|---|
| Open: | 9.57 |
|---|
| Bid: | 9.40 x 1600 |
|---|
| Ask: | 9.46 x 800 |
|---|
| 1y Target Est: | 8.89 |
|---|
| Beta: | 1.26 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 9.35 - 9.63 |
|---|
| 52wk Range: | 4.79 - 9.75 |
|---|
| Volume: | 14,414,490 |
|---|
| Avg Vol (3m): | 19,077,400 |
|---|
| Market Cap: | 12.69B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -3.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Healthcare Stock Stories Starting a Tuesday Buzzat Wall St. Cheat Sheet(Wed, 19 Jun)
- Boston Scientific Inc. (BSX): Today's Featured Health Services Laggardat TheStreet(Wed, 19 Jun)
- BSX Commences U.S. INTREPID TrialZacks(Wed, 19 Jun)
- 4 Stocks Pushing The Health Services Industry Downwardat TheStreet(Wed, 19 Jun)
- Boston Scientific Vercise™ DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's DiseasePR Newswire(Tue, 18 Jun)
- InPlay: Boston Scientific begins patient enrollment in U.S. clinical trial for use of Cercise DBS system in treatment of Parkinson's diseaseBriefing.com(Tue, 18 Jun)
- Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's DiseasePR Newswire(Tue, 18 Jun)
- Gloomy Prospects For Medical Device Companiesat Seeking Alpha(Sun, 16 Jun)
- The 5 Best Medical Device Stocks of 2013at Motley Fool(Sat, 15 Jun)
- S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian IndicesCNW Group(Sat, 15 Jun)
Key Statistics
| Forward P/E (1 yr): | 20.00 |
|---|
| P/S (ttm): | 1.80 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.10 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 2.45 |
|---|
Business Summary
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the tre...
View More